Spots Global Cancer Trial Database for A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
Official Title: A Phase 1/2 Study of BMS-986408 Alone and in Combination With Nivolumab or With Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
Study ID: NCT05407675
Conditions
Study Description
Brief Summary: The primary purpose of this study is to characterize the safety profile of BMS-986408 as monotherapy and in combination with nivolumab or nivolumab and ipilimumab to establish the maximum tolerated dose (MTD). The Recommended Phase 2 Dose (RP2D) that optimizes the pharmacokinetic/pharmacodynamic (PK/PD) relationship of BMS-986408 will also be determined.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0010, Boston, Massachusetts, United States
Local Institution - 0001, Hackensack, New Jersey, United States
Local Institution - 0003, Houston, Texas, United States
Local Institution - 0007, Edmonton, Alberta, Canada
Local Institution - 0011, Hamilton, Ontario, Canada
Local Institution - 0005, Ottawa, Ontario, Canada
Local Institution - 0006, Toronto, Ontario, Canada
Local Institution - 0015, Bordeaux, Aquitaine, France
Local Institution - 0014, Villejuif, Paris, France
Local Institution - 0018, Marseille, , France
Local Institution - 0019, Toulouse, , France
Local Institution - 0024, Málaga, Andalucía, Spain
Local Institution - 0025, Madrid, Madrid, Comunidad De, Spain
Local Institution - 0022, Madrid, , Spain
Local Institution - 0023, Madrid, , Spain
Local Institution - 0021, st.Gallen, Sankt Gallen, Switzerland
Local Institution - 0012, Basel, , Switzerland
Local Institution - 0020, Genève, , Switzerland
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
